These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23151330)

  • 1. [Competing risks in clinical research].
    van Kruijsdijk RC; Eijkemans MJ; Visseren FL
    Ned Tijdschr Geneeskd; 2012; 156(46):A5176. PubMed ID: 23151330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.
    Parpia S; Julian JA; Thabane L; Lee AY; Rickles FR; Levine MN
    Contemp Clin Trials; 2011 Nov; 32(6):829-33. PubMed ID: 21777700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An introduction to competing risks analysis].
    Pintilie M
    Rev Esp Cardiol; 2011 Jul; 64(7):599-605. PubMed ID: 21621892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate?
    Biau DJ; Latouche A; Porcher R
    Clin Orthop Relat Res; 2007 Sep; 462():229-33. PubMed ID: 17496556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.
    Matsuyama Y; Yamaguchi T
    Pharm Stat; 2008; 7(3):202-14. PubMed ID: 17554753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missing data approach to semi-competing risks problems.
    Dignam JJ; Wieand K; Rathouz PJ
    Stat Med; 2007 Feb; 26(4):837-56. PubMed ID: 16755544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing longitudinal data with patients in different disease states during follow-up and death as final state.
    le Cessie S; de Vries EG; Buijs C; Post WJ
    Stat Med; 2009 Dec; 28(30):3829-43. PubMed ID: 19876950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of competing mortality in early breast cancer.
    Mell LK; Jeong JH; Nichols MA; Polite BN; Weichselbaum RR; Chmura SJ
    Cancer; 2010 Dec; 116(23):5365-73. PubMed ID: 20737562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A competing-risks nomogram for sarcoma-specific death following local recurrence.
    Kattan MW; Heller G; Brennan MF
    Stat Med; 2003 Nov; 22(22):3515-25. PubMed ID: 14601016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gibbs sampling for long-term survival data with competing risks.
    Chao EC
    Biometrics; 1998 Mar; 54(1):350-66. PubMed ID: 9544528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence densities in a competing events analysis.
    Grambauer N; Schumacher M; Dettenkofer M; Beyersmann J
    Am J Epidemiol; 2010 Nov; 172(9):1077-84. PubMed ID: 20817786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study.
    Taghipour S; Banjevic D; Fernandes J; Miller AB; Montgomery N; Harvey BJ; Jardine AK
    Breast Cancer Res Treat; 2012 Jul; 134(2):839-51. PubMed ID: 22689090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tree-based models for survival data with competing risks.
    Kretowska M
    Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.